TY - JOUR
T1 - Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort
AU - Solomon, Olivia
AU - Lanata, Cristina M.
AU - Adams, Cameron
AU - Nititham, Joanne
AU - Taylor, Kimberly E.
AU - Chung, Sharon A.
AU - Yazdany, Jinoos
AU - Dall'Era, Maria
AU - Pons-Estel, Bernado A.
AU - Tusié-Luna, Teresa
AU - Tsao, Betty
AU - Morand, Eric
AU - Alarcón-Riquelme, Marta E.
AU - Barcellos, Lisa F.
AU - Criswell, Lindsey A.
N1 - Funding Information:
All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Dr. Barcellos had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health.
Publisher Copyright:
© 2023 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
PY - 2024/4
Y1 - 2024/4
N2 - Objective: Systemic lupus erythematosus (SLE) is an autoimmune disease resulting in debilitating clinical manifestations that vary in severity by race and ethnicity with a disproportionate burden in African American, Mestizo, and Asian populations compared with populations of European descent. Differences in global and local genetic ancestry may shed light on the underlying mechanisms contributing to these disparities, including increased prevalence of lupus nephritis, younger age of symptom onset, and presence of autoantibodies. Methods: A total of 1,139 European, African American, and Mestizos patients with SLE were genotyped using the Affymetrix LAT1 World array. Global ancestry proportions were estimated using ADMIXTURE, and local ancestry was estimated using RFMIXv2.0. We investigated associations between lupus nephritis, age at onset, and autoantibody status with both global and local ancestry proportions within the Major Histocompatibility Complex region. Results: Our results showed small effect sizes that did not meet the threshold for statistical significance for global or local ancestry proportions in either African American or Mestizo patients with SLE who presented with the clinical manifestations of interest compared with those who did not. Conclusion: These findings suggest that local genetic ancestry within the Major Histocompatibility Complex region is not a major contributor to these SLE manifestations among patients with SLE from admixed populations.
AB - Objective: Systemic lupus erythematosus (SLE) is an autoimmune disease resulting in debilitating clinical manifestations that vary in severity by race and ethnicity with a disproportionate burden in African American, Mestizo, and Asian populations compared with populations of European descent. Differences in global and local genetic ancestry may shed light on the underlying mechanisms contributing to these disparities, including increased prevalence of lupus nephritis, younger age of symptom onset, and presence of autoantibodies. Methods: A total of 1,139 European, African American, and Mestizos patients with SLE were genotyped using the Affymetrix LAT1 World array. Global ancestry proportions were estimated using ADMIXTURE, and local ancestry was estimated using RFMIXv2.0. We investigated associations between lupus nephritis, age at onset, and autoantibody status with both global and local ancestry proportions within the Major Histocompatibility Complex region. Results: Our results showed small effect sizes that did not meet the threshold for statistical significance for global or local ancestry proportions in either African American or Mestizo patients with SLE who presented with the clinical manifestations of interest compared with those who did not. Conclusion: These findings suggest that local genetic ancestry within the Major Histocompatibility Complex region is not a major contributor to these SLE manifestations among patients with SLE from admixed populations.
UR - https://www.scopus.com/pages/publications/85183934518
U2 - 10.1002/art.42766
DO - 10.1002/art.42766
M3 - Article
C2 - 38073021
AN - SCOPUS:85183934518
SN - 2326-5191
VL - 76
SP - 614
EP - 619
JO - Arthritis & Rheumatology
JF - Arthritis & Rheumatology
IS - 4
ER -